Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148 (original) (raw)
- Original Paper
- Published: 03 August 1998
Cell Death & Differentiation volume 5, pages 710–715 (1998) Cite this article
- 1624 Accesses
- 116 Citations
- Metrics details
Abstract
The BCR–ABL tyrosine kinase has been implicated as the cause of Philadelphia chromosome (Ph1)-positive leukemias. We report herein that CGP 57148, a selective inhibitor of the ABL tyrosine kinase, caused apoptosis specifically in **bcr–abl**-positive chronic myelogenous leukemia (CML) cells, K562 and KYO-1. Upon treatment with CGP 57148, CRKL, a specific substrate for BCR–ABL that propagates signals via phosphatidylinositol-3′ kinase (PI3K), was dephosphorylated, indicating inhibition of BCR–ABL tyrosine kinase at the cellular level. Likewise, MAPK/ERK, a downstream mediator of Ras, was also dephosphorylated. Caspase activation and cleavage of retinoblastoma protein (pRB) accompanied the development of CGP 57148-induced apoptosis. Inhibition of caspase suppressed apoptosis and the cleavage of pRB, and in turn arrested cells in the G1 phase. These results indicate that CGP 57148 shows apoptogenic and anti-proliferative effects on **bcr–abl**-positive cells by blocking BCR–ABL-initiated signaling pathways.
Similar content being viewed by others
Author information
Authors and Affiliations
- Institute of Molecular and Cellular Biosciences, The University of Tokyo, Tokyo
Shingo Dan, Mikihiko Naito & Takashi Tsuruo - Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan
Takashi Tsuruo
Authors
- Shingo Dan
- Mikihiko Naito
- Takashi Tsuruo
Corresponding author
Correspondence toTakashi Tsuruo.
Additional information
Edited by: Y. Kuchino
Rights and permissions
About this article
Cite this article
Dan, S., Naito, M. & Tsuruo, T. Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148.Cell Death Differ 5, 710–715 (1998). https://doi.org/10.1038/sj.cdd.4400400
- Received: 10 November 1997
- Revised: 06 March 1998
- Accepted: 02 April 1998
- Published: 03 August 1998
- Issue date: 01 August 1998
- DOI: https://doi.org/10.1038/sj.cdd.4400400